SARS-CoV-2 疫苗接种和瘤发生的多重命中假说
Raquel Valdes Angues1, Yolanda Perea Bustos2
1Neurology, Oregon Health and Science University School of Medicine, Portland, USA.
Cureus
|January 18, 2024
概括
对癌症患者的COVID-19疫苗存在担忧. 需要进一步的研究来评估由于疫苗诱导的前瘤原生环境导致癌症进展或复发的潜在风险.
科学领域:
- 瘤学和免疫学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 癌症是一种复杂的疾病,其特点是特定的生物能力.
- 瘤微环境显著影响癌症的进展和转移.
- COVID-19疫苗没有在癌症患者中进行广泛测试,这引发了安全性和有效性问题.
研究的目的:
- 评估COVID-19疫苗接种对癌症患者的潜在影响.
- 为了探索COVID-19疫苗诱导亲瘤原生环境的生物可信性.
- 强调对疫苗对癌症生物学影响的紧急研究的需要.
主要方法:
- 对癌症特征,瘤微环境和疫苗数据的文献综述.
- 对可能将COVID-19疫苗与瘤发生联系起来的生物机制的分析.
- 检查有关疫苗接种后癌症相关结果的不良事件报告 (例如,疫苗不良反应报告系统).
主要成果:
- 某些COVID-19疫苗可能会产生一种支持瘤的环境.
- 潜在的机制包括淋巴缺血,炎症和关键细胞通路的失调.
- 一些报告表明,在接种疫苗后,癌症会恶化或复发.
结论:
- 在向癌症患者推COVID-19疫苗时建议谨慎.
- 紧急评估COVID-19和疫苗对癌症生物学的影响是必要的.
- 公共卫生建议可能需要根据新出现的证据进行调整.
相关概念视频
Rous Sarcoma Virus (RSV) and Cancer
5.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.1K
Cancer Vaccines
368
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
368
Cancers Originate from Somatic Mutations in a Single Cell
11.9K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.9K
Single Nucleotide Polymorphisms-SNPs
15.1K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.1K
Mechanisms of Retrovirus-induced Cancers
5.1K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.1K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K


